ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,402Medicare Part D Prescriptions Filled, Including Refills

Rank: 30 out of 910

$582K Total Retail Price of All Prescriptions

Rank: 119 out of 910

401 Patients Receiving at Least One Drug in Part D
98%Patients 65 Years and Older
67% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arizona
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 401 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

6% of this provider’s 401 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 14,307 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$40 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arizona
LISINOPRIL 782 781 1 2
LEVOTHYROXINE SODIUM 711 708 2 1
DONEPEZIL HCL 671 665 3 32
OMEPRAZOLE 540 532 4 5
FUROSEMIDE 497 497 5 9
NAMENDA 489 484 6 57
CITALOPRAM HBR 461 455 7 19
SIMVASTATIN 364 364 8 3
METOPROLOL TARTRATE 360 360 9 7
RISPERIDONE 357 346 10 67
AMLODIPINE BESYLATE 303 303 11 4
QUETIAPINE FUMARATE 271 262 12 70
DIVALPROEX SODIUM 252 248 13 73
TRAMADOL HCL 238 238 14 25
METFORMIN HCL 236 236 15 6
TRAZODONE HCL 209 209 16 37
SERTRALINE HCL 200 200 17 24
ALENDRONATE SODIUM 197 197 18 22
MIRTAZAPINE 188 184 19 68
POTASSIUM CHLORIDE 187 187 20 18
GABAPENTIN 176 176 21 13
CARVEDILOL 170 170 22 36
WARFARIN SODIUM 152 152 23 11
ISOSORBIDE MONONITRATE ER 141 141 24 81
PAROXETINE HCL 140 137 25 50
SEROQUEL 125 125 26 135
POLYETHYLENE GLYCOL 3350 115 115 27 104
KLOR-CON M10 114 114 28 169
METOPROLOL SUCCINATE 114 114 28 21
FLUOXETINE HCL 107 107 30 49
CLOPIDOGREL 104 104 31 35
CARBIDOPA-LEVODOPA 104 104 31 91
ATORVASTATIN CALCIUM 99 99 33 14
TAMSULOSIN HCL 98 98 34 29
ATENOLOL 95 95 35 10
SPIRONOLACTONE 89 89 36 66
CYMBALTA 83 82 37 58
RANITIDINE HCL 82 82 38 28
GALANTAMINE HBR 80 78 39 241
DIGOXIN 80 80 39 64
PANTOPRAZOLE SODIUM 79 79 41 27
ESCITALOPRAM OXALATE 77 77 42 113
OXYBUTYNIN CHLORIDE 73 73 43 83
HYDROCHLOROTHIAZIDE 73 73 43 12
PLAVIX 70 70 45 53
MAPAP 67 67 46 336
VENLAFAXINE HCL ER 67 64 46 115
TRIAMCINOLONE ACETONIDE 64 58 48 137
ALLOPURINOL 62 62 49 33
GLIPIZIDE 62 62 49 38
ADVAIR DISKUS 59 59 51 45
FAMOTIDINE 58 58 52 101
MECLIZINE HCL 52 52 53 229
LATANOPROST 51 51 54 308
KLOR-CON 10 50 50 55 88
ASPIRIN 50 50 55 388
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 10, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.